Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06705439Completed

A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning (USF)

Role: lead

NCT05606575Completed

A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning - Nelli

Role: lead

NCT04738552Completed

A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning

Role: lead

All 3 trials loaded